by cristiano | Oct 17, 2018
The growth of thyroid nodules, the appearance of other nodules and the increase in thyroid volume can be partially prevented by treatment with levo-thyroxine for TSH-suppressive purposes. However, a clinically significant volume reduction is achieved only with...
by cristiano | Oct 17, 2018
Antiaggregant therapy with acetyl salicilic acid (75-160 mg/daily) is suitable for diabetic patients with previous cardiovascular or cerebrovascular events or with chronic obstructive arteriopathy, and in initial prevention, only in diabetic patients with high...
by cristiano | Oct 17, 2018
The practice of insulin therapy by sliding scale, that is, injecting insulin at set intervals (every 4-6 hours) only if the glycemia goes above a fixed threshold is still common in our country too, but it should be considered an inadequate and ineffective method. This...
by cristiano | Oct 17, 2018
Both the literature and the guidelines of the American Thyroid Association and the European Association of Nuclear Medicine (EANM) agree on this position. However, established clinical practice does not correspond to this “official” position, and, in many cases,...
by cristiano | Oct 17, 2018
There’s no evidence supporting the systematic use of PPI on patients with functional dyspepsia or as prophylaxis during steroid therapy. The primary risk associated with suspending PPI during the course of acid-related disease is the return of symptoms. The...
Recent Comments